Medicus AI Closes the First Tranche of its Series A Funding Round of €5 Million

MedicusMedicus AI GmbH announced the completion of the first tranche of its Series A funding round at €2.75 million, with the purview to close the second tranche of €2.25 million over the coming months.

Medicus works with diagnostic labs to deliver smart features and insights to doctors, in terms of smart testing and diagnosis support, and to patients, in the form of visual and interactive reports, powering continuous healthcare and coaching across all digital platforms.

"At Medicus, we believe that healthcare is in dire need of a user-experience overhaul and that people today are used to experiencing things in a much simpler and clearer fashion, yet healthcare is still complex and impenetrable. We believe this augmentation can unlock massive value that reverberates across the whole healthcare system," said Dr Baher al Hakim, CEO, Medicus.

The Series A funding round will further fuel the company's global expansion, as well as the development of the Medicus diagnostic lab and insurance products, across core markets and in new languages. To date, Medicus supports, German, French, English and Arabic, with Italian, Chinese, Portuguese and Spanish in the pipeline for 2019.

The diagnostic lab space, which makes up Medicus' current core client base, generates an estimated 20 billion reports annually worldwide. However, the industry operates in highly consolidated markets and struggle to differentiate themselves, maintain growthand introduce future-proof business models.

"Our proposition to diagnostic labs is simple. We empower labs to deliver defensible value-add services that augment their existing products. We believe that lab directors only have a few years to decide how to react to the impending waves of innovation incrementally disrupting their industry. The market is struggling under increased commoditization, lowering margins and tightening regulations. Through innovation we help labs build an attractive and integral service offering," explained Dr Baher.

Today Medicus is focused on scalable distribution strategies in existing and new markets from its Vienna headquarters, with offices in Berlin, Paris and Beirut. In late 2018, Medicus signed a market access cooperation with Roche Diagnostics, which will amplify its global reach.

"Medicus is working towards transforming the healthcare sector, simplifying the relations between providers and patients, and leading to better health outcomes," concluded Dr Baher. "Our growing global knowledge and partnerships will help us achieve these outcomes."

For further information, please visit:
http://www.medicus.ai

About Medicus

Medicus is an AI-based platform that converts health data into an interactive experience with easy-to-understand explanations, personalized health insights and smart wellbeing coaching.

Medicus is used by diagnostic labs and health insurance companies to provide patient-friendly health reports and foster continuous and personalized wellbeing coaching.

Medicus is based in Vienna, with offices in Berlin, Paris and Beirut.

Most Popular Now

A New Machine Learning Model can Classif…

Machine learning has improved dramatically in recent years and shown great promise in the field of medical image analysis. A team of research specialists at Dartmouth's Norris Cotton Cancer Center...

Could Blockchain Ensure Integrity of Cli…

UC San Francisco researchers have created a proof-of-concept method for ensuring the integrity of clinical trials data with blockchain. The system creates an immutable audit trail that makes it easy...

3D Child Welfare: How Data, Design and D…

Opinion Article by Rainer Binder, Managing Director, Global Employment and Social Services, Accenture Child welfare remains a pressing challenge for governments around the world, and the statistics are heart-breaking. In the...

Bringing more Human Intelligence to AI, …

The advent of data science, wireless connectivity and sensors, artificial intelligence (AI), and the Internet of Things (IoT) has raised the prospects for digital automation, smart hospital design and the...

Scotland's Digital Health Leaders Recogn…

Scotland's digital health champions have been recognised for their achievements at the Holyrood Connect Digital Health and Care Awards 2019. William Edwards, director of eHealth at NHS Greater Glasgow and...

DMEA 2019: International Exchange on Dig…

9 - 11 April 2019, Berlin, Germany. DMEA (formerly conhIT) is the industry's main event for digital healthcare. In that context, an international exchange of experiences and networking beyond national borders...

Philips to Expand its Radiology Informat…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has signed an agreement to acquire the Healthcare Information Systems business of Carestream Health...

Three Winners of 2019 Sandoz Healthcare …

Sandoz, a Novartis division, announced the winners of the 2019 Sandoz Healthcare Access Challenge (HACk). Sandoz HACk invites entrepreneurs and innovators in the field of digital technology to submit ideas...

UK Sales of Xanax and other Prescription…

Sales of prescription psychiatric drugs such as Xanax and diazepam via darknet online drug markets have increased in the UK at an alarming rate, according to new research by the...

Accenture Wins GLOMO Award for Virtual R…

The Accenture (NYSE: ACN) Virtual Experience Solutions (AVEnueS) has won "Best Mobile VR or AR" at the GSMA GLOMO Awards 2019. The award was presented at MWC19 Barcelona.

Study Finds Robots can Detect Breast Can…

Breast cancer is the most common cancer in women, and despite important improvements in therapy, it is still a major cause for cancer-related mortality, accounting for approximately 500,000 annual deaths...